Chuangui Y. Song
Fuzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Spatial habitat radiomics predicts tertiary lymphoid structure status and identifies an IDO1+ migratory dendritic cell axis in breast cancer.
Journal: Journal for immunotherapy of cancer
Published: August 17, 2026
Association of Physical Activity, Sleep Duration, and Trouble Sleeping With Survival Among US Cancer Survivors: A Population-Based Cohort Study.
Journal: Cancer nursing
Published: June 11, 2026
Computational de novo design of an α-helical peptide targeting LIMD2 suppresses breast cancer cell proliferation.
Journal: International journal of biological macromolecules
Published: January 08, 2026
Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer.
Journal: The New England journal of medicine
Published: December 10, 2025
PET/CT-based quantification of intratumoral heterogeneity for predicting pathological complete response in breast cancer patients treated with neoadjuvant chemotherapy: A multicentre study.
Journal: European journal of nuclear medicine and molecular imaging
Published: November 13, 2025
A novel prognostic signature identifies MFAP4 as a tumor suppressor linking the tumor microenvironment to PI3K/AKT signaling in triple-negative breast cancer.
Journal: Frontiers in immunology
Published: September 19, 2025
Longitudinal tissue analysis reveals microenvironmental changes correlate with combined immunotherapy and targeted therapy response in metastatic breast cancer.
Journal: Journal for immunotherapy of cancer
Published: September 15, 2025
Crosstalk between lipid droplets and autophagy in cancer: A nexus for therapeutic targeting.
Journal: Pharmacological research
Published: July 30, 2025
Genetically engineered macrophages delivering TRAIL targeting the Wnt/β-catenin pathway to induce cytotoxicity against TNBC.
Journal: Cell communication and signaling : CCS
Published: March 24, 2025
Machine learning model for predicting tertiary lymphoid structures and treatment response in triple-negative breast cancer.
Journal: NPJ precision oncology
Published: January 22, 2025
Safety and Efficacy of KN046 in Combination with KN026 in Patients with Advanced HER2-Positive Breast Cancer: A Phase II Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 26, 2024
Last Updated: 09/26/2026